These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8839655)

  • 1. Pattern of sumatriptan use and overuse in general practice.
    Ottervanger JP; Valkenburg HA; Grobbee DE; Stricker BH
    Eur J Clin Pharmacol; 1996; 50(5):353-5. PubMed ID: 8839655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data.
    Gaist D
    Cephalalgia; 1999 Oct; 19(8):735-61. PubMed ID: 10570730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache.
    Plosker GL; McTavish D
    Drugs; 1994 Apr; 47(4):622-51. PubMed ID: 7516861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A within-patient comparison of subcutaneous and oral sumatriptan in the acute treatment of migraine in general practice.
    Gruffydd-Jones K; Hood CA; Price DB
    Cephalalgia; 1997 Feb; 17(1):31-6. PubMed ID: 9051333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experiences from Sweden on the use of subcutaneously administered sumatriptan in migraine and cluster headache.
    Dahlöf C; Ekbom K; Persson L
    Arch Neurol; 1994 Dec; 51(12):1256-61. PubMed ID: 7986182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sumatriptan--side effects and problems in routine clinical practice].
    Marterer A; Wöber C; Schnider P; Aull S; Wessely P
    Med Klin (Munich); 1995 Nov; 90(11):628-33. PubMed ID: 8569629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preemptive oral treatment with sumatriptan during a cluster period.
    Monstad I; Krabbe A; Micieli G; Prusinski A; Cole J; Pilgrim A; Shevlin P
    Headache; 1995; 35(10):607-13. PubMed ID: 8550362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group.
    Ekbom K; Krabbe A; Micieli G; Prusinski A; Cole JA; Pilgrim AJ; Noronha D; Micelli G [corrected to Micieli G]
    Cephalalgia; 1995 Jun; 15(3):230-6. PubMed ID: 7553814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
    Landy SH; Tepper SJ; Wein T; Schweizer E; Ramos E
    Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan overuse in episodic cluster headache: lack of adverse events, rebound syndromes, drug dependence and tachyphylaxis.
    Centonze V; Bassi A; Causarano V; Dalfino L; Cassiano MA; Centonze A; Fabbri L; Albano O
    Funct Neurol; 2000; 15(3):167-70. PubMed ID: 11062845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
    Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients.
    Sternieri E; Pinetti D; Coccia CP; Leone S; Bertolini A; Ferrari A
    J Headache Pain; 2005 Sep; 6(4):319-21. PubMed ID: 16362699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sumatriptan needle-free subcutaneous (Sumavel(®) DosePro™) approved for the acute treatment of migraine, with or without aura, and cluster headaches.
    Freitag FG
    Expert Rev Neurother; 2011 Apr; 11(4):481-90. PubMed ID: 21469920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study.
    Carpay HA; Matthijsse P; Steinbuch M; Mulder PG
    Cephalalgia; 1997 Aug; 17(5):591-5. PubMed ID: 9251875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions attributed to sumatriptan. A postmarketing study in general practice.
    Ottervanger JP; van Witsen TB; Valkenburg HA; Grobbee DE; Stricker BH
    Eur J Clin Pharmacol; 1994; 47(4):305-9. PubMed ID: 7875179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan.
    Rapoport AM; Visser WH; Cutler NR; Alderton CJ; Paulsgrove LA; Davis RL; Ferrari MD
    Neurology; 1995 Aug; 45(8):1505-9. PubMed ID: 7644049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of high sumatriptan dosages during episodic cluster headache: three clinical cases.
    Centonze V; Polito BM; Attolini E; Cassiano MA; Sabbà C; Ricchhetti G; Bassi A; Cavazzuti L; Albano O
    Headache; 1996 Jun; 36(6):389-91. PubMed ID: 8707559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute therapy of episodic and chronic cluster headache with sumatriptan s.c. Results of a one-year long-term study].
    Göbel H; Lindner V; Pfaffenrath V; Ribbat M; Heinze A; Stolze H
    Nervenarzt; 1998 Apr; 69(4):320-9. PubMed ID: 9606683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.